Targeting Myofibroblasts as a Treatment Modality for Dupuytren Disease.
The Journal of hand surgery(2023)
摘要
The combination of PRP and ASCs to induce the differentiation of DMFs into adipocytes may serve to limit surgery to a percutaneous contracture release and biological injection, rather than a moderate or radical fasciectomy, and reduce the recurrence of Dupuytren contracture.
更多查看译文
关键词
Adipose-derived stem cells, Dupuytren disease, fibrosis, myofibroblasts, platelet-rich plasma
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要